UPDATE Sep 19, 2013: A reader sent us a story about the pharmaceutical industry’s influence on the media, helping to hide the fact that prescription drugs often cause violent outbursts, such as the recent Navy Yard shooting. We’ve added the story to the end of this article because it illustrates why we should be very concerned about how far and thoroughly the tentacles of the pharmaceutical industry have spread, and about their influence on our politicians and the hazardous effects on our society and our lives.
How much of the resident-on-resident violence we are hearing about lately in nursing homes might also be caused by the drugs being given to the residents?
Scroll down to read “Media Buries Psychiatric Drug Connections to Navy Shooter” after reading our feature story below.
Pharmaceutical lobbyist backed former NDP health critic… What??
We are truly surprised (and disappointed) to learn that one of the stars of the B.C. NDP had a pharmaceutical industry lobbyist working as a key organizer of his 2011 party leadership campaign.
Several years ago, many of us advocating against elder abuse woke up to the unpleasant reality that the NDP, both provincially and federally, were unwilling to do little more than utter platitudes in the media and publish glossy reports about elder abuse – largely ignoring elder abuse committed by health care providers and public agencies.
The Sep 13, 2013 issue of the weekly Vancouver paper, Georgia Strait reports that lobbyist Marcella Munro was working for Mike Farnworth, the former B.C. NDP Health critic, a close runner-up to opposition leader Adrian Dix in the 2011 NDP leadership race. Mr. Farnworth is now NDP Finance critic and a top contender to replace Mr. Dix as part of the fall-out from the NDP defeat in the May 2013 provincial election in B.C.
Marcella Munro is with the Earnscliffe Strategy Group, and is a registered lobbyist for Rx&D, formally known as “Canada’s Research-Based Pharmaceutical Companies”, as well as a lobbyist for major players in the fish farming, pesticide and natural gas industries. She also lobbies directly for GlaxoSmithKline, Novartis Pharmaceuticals Canada Inc., and Eli Lilly.
Rx&D is (more…)